Search by Drug Name or NDC

    NDC 52083-0653-16 PRESGEN PEDIATRIC 5; 75; 2.5 mg/5mL; mg/5mL; mg/5mL Details

    PRESGEN PEDIATRIC 5; 75; 2.5 mg/5mL; mg/5mL; mg/5mL

    PRESGEN PEDIATRIC is a ORAL SYRUP in the HUMAN OTC DRUG category. It is labeled and distributed by KRAMER NOVIS. The primary component is DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE.

    Product Information

    NDC 52083-0653
    Product ID 52083-653_045188e8-2c41-476a-b86f-75cf57bc2101
    Associated GPIs 43997303100907
    GCN Sequence Number 058870
    GCN Sequence Number Description guaifen/dextromethorphan/PE LIQUID 75-5-2.5/5 ORAL
    HIC3 B4R
    HIC3 Description NON-OPIOID ANTITUSSIVE-DECONGESTANT-EXPECTORANT
    GCN 24395
    HICL Sequence Number 000216
    HICL Sequence Number Description GUAIFENESIN/DEXTROMETHORPHAN HBR/PHENYLEPHRINE
    Brand/Generic Brand
    Proprietary Name PRESGEN PEDIATRIC
    Proprietary Name Suffix n/a
    Non-Proprietary Name GUAIFENESIN, PHENYLEPHRINE HCL,DEXTROMETHORPHAN HYDROBROMIDE
    Product Type HUMAN OTC DRUG
    Dosage Form SYRUP
    Route ORAL
    Active Ingredient Strength 5; 75; 2.5
    Active Ingredient Units mg/5mL; mg/5mL; mg/5mL
    Substance Name DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESIN; PHENYLEPHRINE HYDROCHLORIDE
    Labeler Name KRAMER NOVIS
    Pharmaceutical Class Adrenergic alpha1-Agonists [MoA], Decreased Respiratory Secretion Viscosity [PE], Expectorant [EPC], Increased Respiratory Secretions [PE], Sigma-1 Agonist [EPC], Sigma-1 Receptor Agonists [MoA], Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH FINAL
    Application Number part341
    Listing Certified Through 2024-12-31

    Package

    NDC 52083-0653-16 (52083065316)

    NDC Package Code 52083-653-16
    Billing NDC 52083065316
    Package 480 mL in 1 BOTTLE (52083-653-16)
    Marketing Start Date 2011-03-24
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 12fb91e5-6059-4b3a-a2de-762aa51a25b7 Details

    Revised: 10/2022